The study on hydroxychloroquine co-signed by Didier Raoult “casts a little stigma on research in general”, considers the president of the French Society of Pharmacology and Therapeutics

The study on hydroxychloroquine co-signed by Didier Raoult “throws some opprobrium on research in general“, estimates Saturday June 3 on franceinfo Professor Dominique Deplanque, president of the French Society of Pharmacology and Therapeutics. Dominique Deplanque is also co-signatory of a forum published in the world Sunday May 28, denouncing “the serious failings” from the study of the Marseille doctor.

>>> Study co-signed by Didier Raoult on hydroxychloroquine: the Medicines Agency announces that it will take legal action

“What matters is to remind everyone how, in 2023, drug research must be carried out, so that this type of deviation, if not deviation, cannot be reproduced later.“, explains Dominique Deplanque. He considers that the study in question, published without proofreading by peers, falls within the “belief“and not science:”Everything has been done to highlight a potential effect of these treatments, even though all the well-conducted studies informed us from the summer of 2020 that this treatment was totally ineffective.“, he insists.

He describes as “position of victimization which is a defense like any other“, the reaction of the Marseille doctor, who described as “stupid grandstand” the text published in Le Monde. “We can not question the past of Mr. Raoult. Certainly, he is a great scientist in the field of microbiology. But microbiology is not drug evaluation“, concludes Professor Deplanque.

>>> Covid-19: we summarize the controversy around Didier Raoult’s “wild” therapeutic trial in seven acts

For its part, the National Medicines Safety Agency (ANSM) announces on Saturday June 3 that it “prepares to take legal actionregarding the publication of the controversial study.